DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS
The invention is directed to methods for the a method for treating overexpression of the erbB2 in a mammal in need of treatment by administering to the mammal a therapeutically effective amount of a first inhibitor of an erbB2 receptor and then, after an interval of less than 24 hours, administering...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NOE, DENNIS ALAN CONNELL, RICHARD DAMIAN STEYN, STEFANUS JOHANNES BHATTACHARYA, SAMIT K MOYER, JAMES DALE JANI, JITESH PRANLAL |
| description | The invention is directed to methods for the a method for treating overexpression of the erbB2 in a mammal in need of treatment by administering to the mammal a therapeutically effective amount of a first inhibitor of an erbB2 receptor and then, after an interval of less than 24 hours, administering to the mammal from one to six therapeutically effective amounts of the same or different inhibitor of the erbB2 receptor. The invention is also directed to a slow daily infusion of the erbB2 inhibitor. The overexpression of the erbB2 receptor can result in abnormal cell growth and lead to cancer. By the methods of the invention, the efficacy and safety of the inhibitors is increased. The invention is also directed to kits for facilitating the dose administration method of the invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1658080A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1658080A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1658080A13</originalsourceid><addsrcrecordid>eNrjZNB18Q_29HNXCHb2cHUJ9XFVcPMPUnBUcA1ycjJScPQL8XR29HN2BQq5u_qFBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAEMzUwsDCwNHQ2MilAAAQJsklA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS</title><source>esp@cenet</source><creator>NOE, DENNIS ALAN ; CONNELL, RICHARD DAMIAN ; STEYN, STEFANUS JOHANNES ; BHATTACHARYA, SAMIT K ; MOYER, JAMES DALE ; JANI, JITESH PRANLAL</creator><creatorcontrib>NOE, DENNIS ALAN ; CONNELL, RICHARD DAMIAN ; STEYN, STEFANUS JOHANNES ; BHATTACHARYA, SAMIT K ; MOYER, JAMES DALE ; JANI, JITESH PRANLAL</creatorcontrib><description>The invention is directed to methods for the a method for treating overexpression of the erbB2 in a mammal in need of treatment by administering to the mammal a therapeutically effective amount of a first inhibitor of an erbB2 receptor and then, after an interval of less than 24 hours, administering to the mammal from one to six therapeutically effective amounts of the same or different inhibitor of the erbB2 receptor. The invention is also directed to a slow daily infusion of the erbB2 inhibitor. The overexpression of the erbB2 receptor can result in abnormal cell growth and lead to cancer. By the methods of the invention, the efficacy and safety of the inhibitors is increased. The invention is also directed to kits for facilitating the dose administration method of the invention.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060524&DB=EPODOC&CC=EP&NR=1658080A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060524&DB=EPODOC&CC=EP&NR=1658080A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NOE, DENNIS ALAN</creatorcontrib><creatorcontrib>CONNELL, RICHARD DAMIAN</creatorcontrib><creatorcontrib>STEYN, STEFANUS JOHANNES</creatorcontrib><creatorcontrib>BHATTACHARYA, SAMIT K</creatorcontrib><creatorcontrib>MOYER, JAMES DALE</creatorcontrib><creatorcontrib>JANI, JITESH PRANLAL</creatorcontrib><title>DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS</title><description>The invention is directed to methods for the a method for treating overexpression of the erbB2 in a mammal in need of treatment by administering to the mammal a therapeutically effective amount of a first inhibitor of an erbB2 receptor and then, after an interval of less than 24 hours, administering to the mammal from one to six therapeutically effective amounts of the same or different inhibitor of the erbB2 receptor. The invention is also directed to a slow daily infusion of the erbB2 inhibitor. The overexpression of the erbB2 receptor can result in abnormal cell growth and lead to cancer. By the methods of the invention, the efficacy and safety of the inhibitors is increased. The invention is also directed to kits for facilitating the dose administration method of the invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB18Q_29HNXCHb2cHUJ9XFVcPMPUnBUcA1ycjJScPQL8XR29HN2BQq5u_qFBPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUknjXAEMzUwsDCwNHQ2MilAAAQJsklA</recordid><startdate>20060524</startdate><enddate>20060524</enddate><creator>NOE, DENNIS ALAN</creator><creator>CONNELL, RICHARD DAMIAN</creator><creator>STEYN, STEFANUS JOHANNES</creator><creator>BHATTACHARYA, SAMIT K</creator><creator>MOYER, JAMES DALE</creator><creator>JANI, JITESH PRANLAL</creator><scope>EVB</scope></search><sort><creationdate>20060524</creationdate><title>DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS</title><author>NOE, DENNIS ALAN ; CONNELL, RICHARD DAMIAN ; STEYN, STEFANUS JOHANNES ; BHATTACHARYA, SAMIT K ; MOYER, JAMES DALE ; JANI, JITESH PRANLAL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1658080A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NOE, DENNIS ALAN</creatorcontrib><creatorcontrib>CONNELL, RICHARD DAMIAN</creatorcontrib><creatorcontrib>STEYN, STEFANUS JOHANNES</creatorcontrib><creatorcontrib>BHATTACHARYA, SAMIT K</creatorcontrib><creatorcontrib>MOYER, JAMES DALE</creatorcontrib><creatorcontrib>JANI, JITESH PRANLAL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NOE, DENNIS ALAN</au><au>CONNELL, RICHARD DAMIAN</au><au>STEYN, STEFANUS JOHANNES</au><au>BHATTACHARYA, SAMIT K</au><au>MOYER, JAMES DALE</au><au>JANI, JITESH PRANLAL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS</title><date>2006-05-24</date><risdate>2006</risdate><abstract>The invention is directed to methods for the a method for treating overexpression of the erbB2 in a mammal in need of treatment by administering to the mammal a therapeutically effective amount of a first inhibitor of an erbB2 receptor and then, after an interval of less than 24 hours, administering to the mammal from one to six therapeutically effective amounts of the same or different inhibitor of the erbB2 receptor. The invention is also directed to a slow daily infusion of the erbB2 inhibitor. The overexpression of the erbB2 receptor can result in abnormal cell growth and lead to cancer. By the methods of the invention, the efficacy and safety of the inhibitors is increased. The invention is also directed to kits for facilitating the dose administration method of the invention.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1658080A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DOSING SCHEDULE FOR A ERBB2 ANTICANCER AGENTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A50%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NOE,%20DENNIS%20ALAN&rft.date=2006-05-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1658080A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |